Pharmaceutical firms face damage suit over cold remedies

Recently, six Korean people filed a 500 million won damage suit against the government and some cold drug makers, claiming they had suffered side effects from medicines containing phenylpropanolamine (PPA), which allegedly cause hemorrhagic strokes.

It is the fist time Koreans have taken legal action against drug makers and the government since the Korea Food and Drug Administration on Augus...